Erectile dysfunction — all decisions

The Board granted an effective date of April 1, 2023 for the grant of service connection for prostate cancer with radical prostatectomy and erectile dysfunction.

The Board denied a compensable evaluation for scars of the anterior trunk and remanded claims for service connection for erectile dysfunction, hemorrhoids, hypertension, and an acquired psychiatric disability, to include major depressive disorder and anxiety.

The Board denied an earlier effective date for the grant of service connection for erectile dysfunction, finding that August 18, 2022, is the earliest possible effective date.

The Board granted an effective date of January 1, 2016, for entitlement to special monthly compensation based on loss of use of a creative organ due to service-connected erectile dysfunction.

The Board remands the claim for a more adequate medical opinion addressing causation and aggravation of erectile dysfunction by Meniere's Syndrome, including the use of Meclizine.

The Board denied service connection for urinary frequency and erectile dysfunction as the evidence did not support a current diagnosis of these conditions during the pendency of the claim.

The Board granted presumptive service connection for prostate cancer, and service connection for erectile dysfunction and incontinence as secondary to the service-connected prostate cancer.

The Board denied service connection for a neck disability, right shoulder disability, insomnia, and erectile dysfunction as there was no evidence of these conditions during or shortly after active duty, and the current conditions are not shown to be related to service.

The Board denied a rating in excess of 50 percent for PTSD, denied an initial rating in excess of 10 percent for allergic rhinitis, granted an initial rating of 10 percent for opioid induced constipation, and remanded several service connection claims and the TDIU claim.

The Board denied the Veteran's appeal for an earlier effective date for service connection for erectile dysfunction as secondary to PTSD and special monthly compensation based on loss of use of a creative organ.

The Board granted an earlier effective date of May 18, 2023, for the award of service connection for erectile dysfunction secondary to a service-connected psychiatric disorder and special monthly compensation based on loss of use of a creative organ.

The Board denied service connection for acquired mood disorder, bilateral hearing loss, and increased ratings for spine disability and right lower extremity radiculopathy. The claims for an acquired psychiatric disability, ED, and bilateral knee pain were remanded.

The appeals for service connection for sleep apnea, depression, erectile dysfunction, hypertension, sleep disturbances (now claimed as insomnia), and fatigue were dismissed due to improper concurrent elections.

The Board granted service connection for right wrist strain, testicular pain, TMJ with bruxism, and erectile dysfunction (secondary to PTSD), while denying increased ratings for PTSD, left wrist strain, abdominal scarring status post appendectomy, chronic sinusitis, IBS, and bilateral hearing loss. The Board also granted special monthly compensation based on the loss of use of a creative organ.

The appeal for service connection for a back disability and neck disability was dismissed as moot, with full benefits granted. Other claims were remanded for further review.

The Board denied an initial compensable rating for sinusitis and higher ratings from November 16, 2017 to March 24, 2022, but granted a 50 percent rating from March 24, 2022. The claim for service connection for erectile dysfunction was remanded.

The Board denied a compensable rating for bilateral sensorineural hearing loss and denied service connection for insomnia, while granting service connection for chronic sinusitis, cervical spine disorder, ED, and hemorrhoids.

The Board remands the claims for service connection for erectile dysfunction and entitlement to a total disability rating based on individual unemployability due to a need for an adequate medical opinion.

The Board denied service connection for obstructive sleep apnea, headaches, erectile dysfunction, and hypertension. However, it granted service connection for irritable bowel syndrome and hypothyroidism.

The Board granted an earlier effective date of March 11, 2022, for the grant of service connection for PTSD and erectile dysfunction.